Menu

Andrew Alliance Announces Co-Marketing Agreement with Arcis Biotechnology to Offer Hands-free Nucleic Acid Stabilization and Preparation

May 14, 2019
Andrew Alliance

Andrew Alliance and Arcis Biotechnology today announced a co-marketing relationship for deploying protocols that automate sample preparation for nucleic acid analysis on Andrew Alliance platforms. Under the terms of the agreement, Andrew Alliance and Arcis will promote the use of Arcis reagents for DNA and RNA preparation in conjunction with Andrew Alliance platforms such as the Andrew+ Pipetting Robot and OneLab Software.

“We are excited to announce this exciting relationship with Andrew Alliance,” said Arcis CEO Peter Whitehurst. “The Andrew+ robot combined with our Arcis reagents represent a hands-free solution for stabilizing and preparing samples for RNA or DNA analysis, especially in infectious disease detection workflows, where speed is a key requirement.”

The groundbreaking Andrew+ design benefits from 6 years of user feedback on the award-winning Andrew Pipetting Robot. Andrew+ offers fully automated pipetting, as well as more complex manipulations, using a wide range of DOMINO Accessories and Andrew Alliance electronic pipettes. It executes OneLab protocols, enabling rapid transition from laborious manual procedures to error-free, robotic workfows.

“Our agreement with Arcis will support our customers using a single platform to not only complete sample preparation, but also prepare for downstream analysis.” said Piero Zucchelli, CEO of Andrew Alliance. “This simple protocol reduces hands-on time as well as total time spent on getting samples ready for analysis, while not requiring anything more than Andrew+.”

Arcis reagents are an ultra-fast sample preparation system for the preparation of DNA and RNA, with the added benefit of preserving and protecting nucleic acids without temperature control or additional processing. The fast and convenient protocol uses a simple 2 step process that enables you to go from sample to amplifiable DNA or RNA in under 3 minutes. The kits are compatible with whole blood, blood plasma, urine, cell cultures, sputum, food, soil and many other sample types. The nucleic acids are suitable for direct use in PCR, isothermal amplification and sequencing.



June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.